Healthpeak Properties Inc. (DOC) — RQD Stock Rating Cockpit

Per the Roarable RQD rating, DOC scores 58 out of 100, graded D+, with the verdict "Roarable Sell — Weak Fundamentals / Trim." The five pillars break down as follows:

• Fundamental Cash Engine: 13 / 20. Per the RQD rating, this pillar reflects ROIC of 0.6% and an FCF yield of 9.38%. For a prospective investor, the high FCF yield is the main support, while the very low ROIC indicates that capital deployed in the business is earning little return relative to its size.
• Whale 13F Flow: 9 / 20. Per the RQD rating, this pillar captures institutional accumulation and options positioning. The modest score suggests limited institutional conviction in the source data.
• Insider Conviction: 13 / 20. Per the RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. The mid-range score signals neither strong insider buying nor strong selling in the scoring model.
• Macro Regime Fit: 8 / 20. Per the RQD rating, this pillar reflects beta of 1.02 and sector sensitivity. The low score indicates the stock's profile is weakly aligned with the regime the model assesses.
• Forensic Balance Sheet: 15 / 20. Per the RQD rating, this pillar reflects Altman Z of 2.5, Piotroski F of 8/9, and Debt/Equity of 0.5. This is the strongest pillar and is the main reason the score is not lower.

Taken together, the investor implications are: the upside case rests on the cash-flow yield and a balance sheet the model rates as sound, while the valuation tradeoff is weighed against an EV/EBITDA of 95 and a ROIC of 0.6%, which together suggest that cash generation is not translating efficiently into returns. The weak macro-fit and institutional-flow scores mean the model sees limited external tailwinds. This is an analytical reading of the scores, not a personalized recommendation.

Per the SEC financials, revenue rose from $527.4M in FY 2023 to $604.0M in FY 2025, while net income fell from $306.0M to $71.3M over the same period. Per the market data, operating margin is 14.4%, net margin is 11.8%, and gross margin is 0%, with ROIC at 0.6%. The Altman Z-Score is 2.5 and the Piotroski F-Score is 8/9, per the RQD rating. Debt rose from $1680.8M in FY 2023 to $5415.1M in FY 2025, and the RQD rating reports Debt/Equity of 0.5.

Per the recent news wire, six items are tagged to DOC, each with a YELLOW light and MARKET WIRE impact label. The headlines are generic market-coverage pieces: one notes the stock "Still Looks Cheap Following Its 31% Run," another asks whether the company "Can ... Keep Funding Its Dividend," and another covers a Barclays "Hold" rating. The news wire does not supply quantified catalyst details. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded.

Risk watch items: the dividend-coverage question raised in the news wire and the rise in reported debt in the SEC financials.

• What is the source of the EV/EBITDA of 95, and how does it reconcile with a 14.4% operating margin and reported net income that fell from $306.0M to $71.3M?
• How does FY 2025 reported debt of $5415.1M compare with cash of $467.5M, and what is the debt maturity and refinancing profile?
• What drives the gap between an FCF yield of 9.38% and a ROIC of 0.6%, given the reported FCF of $1224.8M in FY 2025?
• What are the P/E and EPS figures, which the source reports as unavailable, and how does the dividend yield of 6.5% compare on a per-share earnings basis?
• What institutional or insider transactions underlie the 13F and Form 4 pillar scores, given that the holders section is empty?